Aspirin Use for Secondary Prevention Amid Negative Messaging in Patients With Cardiovascular Disease - Top-Institutions - MDSpire

Aspirin Use for Secondary Prevention Amid Negative Messaging in Patients With Cardiovascular Disease

By
Jeremy R. Van’t Hof
Sue Duval
Niki Oldenburg
Milton Eder
Russell V. Luepker
June 4, 2026
0 min

Jama Network Open

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

#1

University of Minnesota

Minneapolis, MN
Key Differentiators
- Cardiology
#2

Michigan Anticoagulation Quality Improvement Initiative

Ann Arbor, MI
Key Differentiators
- Cardiology
#3

Macula & Retina Institute

Houston, TX
Key Differentiators
- Cardiology
#4

Deutsches Herzzentrum München

Munich, Bavaria
Key Differentiators
- Cardiology
#5

Medizinische Klinik and Poliklinik Innere Medizin I, Klinikum rechts der Isar, Technische Universität München

Munich, Bavaria
Key Differentiators
- Cardiology

Original Source(s)

Jama Network Open

Aspirin Use for Secondary Prevention Amid Negative Messaging in Patients With Cardiovascular Disease

by Jeremy R. Van’t Hof, Sue Duval, Niki Oldenburg, Milton Eder, Russell V. Luepker
June 4, 2026

Related Content

Frontiers In Cardiovascular Medicine

Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins

Frontiers In Cardiovascular Medicine

Proposing an explanatory framework based on the fear-avoidance model: a mixed-methods analysis of kinesiophobia in patients after percutaneous coronary intervention in home-based cardiac rehabilitation

by Li Sun, Chunlei Nie, Dandan Xu, Lan Wei, Weiwei Zong, Yanli Hu, Yuan Li, Xinyue Zhang
June 4, 2026

Frontiers In Digital Health

Computational modelling for personalized transcatheter aortic valve replacement planning: a systematic review of complications and decision support